Form D · Other Technology
KSANA HEALTH INC.
Eugene, OR · CIK 0001866217
Offering snapshot reported Sep 6, 2022 · SEC filing
- Reported sold
- $1.23M Offering amount: $2.5M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 22, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 6, 2022 | Initial | $1,226,997 | No comparison | 4 | SEC filing |
| Oct 12, 2021 | Initial | $999,999 | No comparison | 9 | SEC filing |
| Jun 22, 2021 | Initial | $1,562,499 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-458092
Sale and issuance of Series Seed-4 Preferred Stok and the underlying shares of Common Stock issuable upon conversion thereof
Source: Form D, filed Sep 6, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nicholas Allen | Director, Executive |
| Jan Hardorp | Director |
| Phillip Scripa | Executive |
| William Shortt | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
2288 Alder Street
Eugene, OR, 97405
Eugene, OR, 97405